HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christina Kuhn Selected Research

1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)

6/2017Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
4/2016Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR).
1/2016Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells.
5/2012Expression of different carbohydrate tumour markers and galectins 1 and 3 in normal squamous and malignant epithelia of the upper aaerodigestive tract.
12/2011Is galectin-1 a trigger for trophoblast cell fusion?: the MAP-kinase pathway and syncytium formation in trophoblast tumour cells BeWo.
2/2011Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.
7/2007Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
10/2006Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christina Kuhn Research Topics

Disease

45Neoplasms (Cancer)
11/2021 - 10/2006
24Breast Neoplasms (Breast Cancer)
01/2022 - 01/2005
15Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 06/2016
15Carcinoma (Carcinomatosis)
03/2021 - 03/2005
13Endometrial Neoplasms (Endometrial Cancer)
06/2020 - 07/2007
12Habitual Abortion (Recurrent Miscarriage)
11/2021 - 12/2010
11Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 02/2009
11Spontaneous Abortion (Miscarriage)
11/2021 - 12/2010
9Neoplasm Metastasis (Metastasis)
01/2022 - 01/2005
9Carcinogenesis
03/2021 - 01/2005
7Adenocarcinoma
12/2019 - 01/2005
6Pre-Eclampsia (Preeclampsia)
01/2022 - 12/2005
5Inflammation (Inflammations)
03/2021 - 03/2013
5Choriocarcinoma
03/2019 - 12/2011
5Trophoblastic Neoplasms (Trophoblastic Tumor)
10/2016 - 10/2006
4Endometriosis
10/2021 - 11/2012
4Lymphatic Metastasis
11/2014 - 01/2005
4Ductal Carcinoma
05/2009 - 01/2005
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 05/2010
3Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2019 - 12/2015
2HELLP Syndrome
01/2022 - 09/2008
2Vulvar Neoplasms (Vulvar Cancer)
03/2021 - 12/2020
2Gestational Diabetes (Gestational Diabetes Mellitus)
10/2020 - 03/2020
2Hydatidiform Mole (Molar Pregnancy)
01/2020 - 07/2007
2Endometrioid Carcinoma
09/2010 - 07/2007
2Hemolysis
09/2008 - 11/2006
2Noninfiltrating Intraductal Carcinoma (DCIS)
07/2007 - 01/2005
2Carcinoma in Situ
07/2007 - 03/2005

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2005
19ParaffinIBA
01/2021 - 01/2005
12Estrogen ReceptorsIBA
11/2021 - 07/2007
11Activins (Activin)IBA
05/2016 - 01/2005
11Inhibins (Inhibin)IBA
07/2011 - 01/2005
81-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
06/2017 - 10/2006
8Monoclonal AntibodiesIBA
05/2012 - 01/2005
7AntibodiesIBA
10/2021 - 02/2009
7Galectin 1 (LGALS1)IBA
10/2019 - 10/2006
7Hormones (Hormone)IBA
10/2016 - 07/2007
6GTP-Binding Proteins (G-Protein)IBA
11/2021 - 11/2012
6Messenger RNA (mRNA)IBA
11/2021 - 03/2005
6Galectins (Galectin)IBA
02/2021 - 05/2012
6Estrogen Receptor alphaIBA
01/2018 - 12/2005
5Cadherins (E-Cadherin)IBA
01/2022 - 07/2007
5Histones (Histone)IBA
11/2021 - 02/2017
5CytokinesIBA
11/2021 - 10/2020
5Mucin-1 (CA 15-3 Antigen)IBA
02/2021 - 07/2007
5CarbohydratesIBA
01/2021 - 05/2010
5Estrogens (Estrogen)FDA Link
01/2021 - 07/2007
5Tumor Biomarkers (Tumor Markers)IBA
05/2010 - 01/2005
4Lysine (L-Lysine)FDA Link
11/2021 - 03/2020
4histone H3 trimethyl Lys4IBA
11/2021 - 03/2020
4EnzymesIBA
11/2021 - 11/2006
4Prostaglandin Receptors (Prostaglandin Receptor)IBA
03/2021 - 07/2017
4GlycodelinIBA
01/2021 - 03/2005
4AntigensIBA
01/2021 - 07/2007
4ProstaglandinsIBA
12/2020 - 07/2017
4Formaldehyde (Formol)FDA Link
07/2020 - 07/2007
4Galectin 3 (LGALS3)IBA
01/2020 - 02/2011
4Thyroid HormonesIBA
01/2019 - 01/2015
4Oncogene Proteins (Oncogene Protein)IBA
10/2018 - 06/2016
4Estrogen Receptor betaIBA
11/2007 - 12/2005
3Co-Repressor ProteinsIBA
11/2021 - 01/2019
3Bromodeoxyuridine (BrdU)IBA
03/2021 - 03/2020
3LigandsIBA
01/2021 - 01/2019
3CA-19-9 Antigen (CA 19-9 Antigen)IBA
01/2021 - 05/2010
3Biomarkers (Surrogate Marker)IBA
12/2020 - 01/2018
3Dinoprostone (PGE2)FDA Link
11/2020 - 01/2018
3Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
08/2020 - 01/2015
3Thomsen-Friedenreich antigenIBA
02/2020 - 10/2006
3EpitopesIBA
02/2020 - 05/2009
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2020 - 01/2018
3Glycoproteins (Glycoprotein)IBA
05/2016 - 01/2007
3Progesterone Receptors (Progesterone Receptor)IBA
12/2012 - 07/2007
3inhibin beta A subunitIBA
05/2009 - 01/2005
3Steroid Receptors (Steroid Receptor)IBA
11/2007 - 07/2007
2Interleukin-7 (Interleukin 7)IBA
01/2021 - 10/2020
2Sialyl Lewis X AntigenIBA
01/2021 - 02/2009
2Protein Isoforms (Isoforms)IBA
08/2020 - 01/2015
2Galectin 2 (LGALS2)IBA
03/2020 - 04/2016
2Calcitriol (Calcijex)FDA LinkGeneric
03/2020 - 12/2018
2ProgesteroneFDA LinkGeneric
03/2019 - 07/2007
2Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2019 - 01/2019
2Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
02/2018 - 07/2017
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2018 - 12/2011
2Carrier Proteins (Binding Protein)IBA
01/2018 - 06/2017
2Phytoestrogens (Phytoestrogen)IBA
10/2016 - 01/2013
2SteroidsIBA
09/2016 - 07/2007
2Janus Kinase 2IBA
01/2016 - 12/2011
2Phosphotransferases (Kinase)IBA
01/2016 - 12/2011
2tyrosine receptor (receptor, tyrosine)IBA
01/2016 - 12/2011
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2016 - 12/2011
2Estradiol (Delestrogen)FDA LinkGeneric
01/2013 - 07/2007
2Peptides (Polypeptides)IBA
05/2010 - 02/2009
2inhibin-alpha subunitIBA
05/2009 - 07/2007
2progesterone receptor AIBA
11/2007 - 07/2007
1Thyroid Hormone Receptors beta (TR beta)IBA
02/2022
1Interleukin-18 (Interleukin 18)IBA
11/2021
1ElementsIBA
11/2021
1Small Interfering RNA (siRNA)IBA
11/2021

Therapy/Procedure

12Therapeutics
10/2021 - 12/2012